Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market definitions
1.3 Base estimates and calculations
1.3.1 Data collection
1.4 Forecast calculations
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Continuous glucose monitoring market industry 360° synopsis, 2018 - 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends (USD Million & Units)
2.1.3 Component trends
2.1.4 End-use trends
Chapter 3 Continuous Glucose Monitoring Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of people suffering from diabetes across the world
3.2.1.2 Rise in demand for continuous monitoring devices globally
3.2.1.3 Technological advancements in devices
3.2.1.4 Increasing government initiatives to generate awareness regarding diabetes
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost related to devices
3.2.2.2 Stringent regulatory scenario
3.3 Growth potential analysis
3.3.1 By component
3.3.2 By end-use
3.4 COVID- 19 impact analysis
3.5 Technological landscape
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Vendor matrix analysis, 2022
4.6 Competitive analysis of major market players
4.7 Competitive positioning matrix
4.8 Strategic outlook matrix
Chapter 5 Continuous Glucose Monitoring Market Size and Forecast, By Component (USD Million)
5.1 Key trends, by component
5.2 Transmitters
5.3 Sensors
5.4 Receivers
Chapter 6 Continuous Glucose Monitoring Market Size and Forecast, By End-use (USD Million)
6.1 Key trends, by end-use
6.2 Hospitals
6.3 Home care settings
6.4 Diagnostic centers & clinics
6.5 Others
Chapter 7 Continuous Glucose Monitoring Market Size and Forecast, By Region (USD Million & Units)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Russia
7.3.7 Poland
7.3.8 Switzerland
7.3.9 Norway
7.3.10 Finland
7.3.11 Sweden
7.3.12 Denmark
7.3.13 The Netherlands
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Taiwan
7.4.7 Indonesia
7.4.8 Vietnam
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Colombia
7.5.5 Chile
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Israel
Chapter 8 Company Profiles
8.1 Ascensia Diabetes Care Holdings AG. (Senseonics, Inc.)
8.2 Lifescan, Inc.
8.3 Universal Biosensors
8.4 Nova Biomedical
8.5 Med Trust
8.6 Taidoc Technology Corporation
8.7 Roche AG.
8.8 Dexcom
8.9 i-SENS, Inc.
8.10 Abbott Laboratories
8.11 Trividia Health
8.12 Pinnacle technology
8.13 Medtronic
